Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06431477
PHASE4
Efficacy and Safety of Telmisartan Compared With Losartan
Sponsor: Chong Kun Dang Pharmaceutical
View on ClinicalTrials.gov
Summary
A study to evaluate the efficacy and safety of telmisartan compared with losartan in patients with diabetic nephropathy and hypertension
Official title: A Multi-center, Randomized, Open-label, Active Comparator-controlled, Phase 4 Clinical Trial To Evaluate the Efficacy and Safety of Telmisartan Compared With Losartan in Patients With Diabetic Nephropathy and Hypertension
Key Details
Gender
All
Age Range
19 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
98
Start Date
2023-04-19
Completion Date
2025-10-31
Last Updated
2024-05-28
Healthy Volunteers
No
Conditions
Interventions
DRUG
telmisartan
QD, PO
DRUG
Losartan
QD, PO
Locations (1)
Severance Hospital
Seoul, South Korea